Titan, Lupin, Indian Hotels: How to trade Rakesh Jhunjhunwala-owned stocks

Titan and Lupin seem poised for solid gains among Rakesh Jhunjhunwala's portfolio, while shares of Lupin, Star Health and Jubilant Pharmova can be avoided for now.

The recent market fall, wherein the key benchmark indices - the Sensex and the Nifty tanked over 15 per cent from their respective highs wiped-out a considerable amount of investors wealth. 

Ace investor, Rakesh Jhunjhunwala, too, was not spared. His portfolio has taken a severe beating - among select stocks Titan has tanked 20 per cent from its all-time high of Rs 2,768.  Shares of Lupin have been continuously hitting a fresh 52-week low, and the stock has shed as much as 70 per cent from its historic peak of Rs 2,088.

Given the mass following for the ace investor, here's a quick chart check on some of this portfolio holdgins with a short-to-medium term perspective.

Titan Company Ltd (TITAN)

Outlook: May rally 15% after conquering 200-DMA

Shares of Titan Company managed to rebound and cross the 50-weekly moving average (WMA) placed at Rs 2,253 level, but until the 200-DMA positioned at Rs 2,344 mark is not crossed, the upside bias may not yield much returns. At present, the stock is well placed above the immediate support of Rs 2,100 and attempts to conquer the 200-DMA. As and when this happens, the stock could easily rally 10 to 15 per cent and hit the Rs 2,800 mark. CLICK HERE FOR THE CHART

Indian Hotels Co. Ltd (INDHOTEL)

Outlook: Bigger outlook points at 50 per cent jump

As long as Indian Hotels does not breach the Rs 200-mark with high volume, the trend indicates a good entry point for long-term gains. The broader outlook points for a rally towards Rs 350 with a symmetrical triangle breakout and continuous accumulation in the range of Rs 220 to Rs 200 levels, according to the weekly chart. CLICK HERE FOR THE CHART

Jubilant Pharmova Ltd (JUBLPHARMA)

Outlook: Trades at the lower end of the price action.

The stock has been on a weak footing and falling continuously with every possible reversals getting sold-off. The shares have dropped 60 per cent from the historic peak of Rs 1,038 recorded in March 2021. The counter trades under all the major moving averages, whether it is 50-day moving average (DMA), 100-DMA or the 200-DMA. The stock has failed to conquer the 100-DMA and 200-DMA since the last one year signalling selling pressure and stiff hurdles on the upside. It did touch a fresh 52-week high on May 31, 2022 and as long as it trades on the lower end of the price, it is advisable to stay sidelines.  CLICK HERE FOR THE CHART

Lupin Ltd (LUPIN)

Outlook: Needs to bounce back 

Lupin trades under the 200-monthly moving average (MMA) located at Rs 720 with extreme bearishness. The stock needs to bounce back soon, otherwise the trend could remain bearish for a medium-term perspective. The next support levels for the stock are at Rs 600 and 580 levels.  CLICK HERE FOR THE CHART

Star Health and Allied Insrnce Com Ltd (STARHEALTH)

Outlook: Needs to take out Rs 750 decisively

The stock is down 18 per cent from the debut price and trades with a sluggish bias. The breakout stands at Rs 750, its horizontal resistance, which the stock needs to take out with firm volume, indicates the daily chart. So far, Rs 600 has remained a support mark with the stock lingering around Rs 650 level. CLICK HERE FOR THE CHART